Streptokinase versus alteplase in acute myocardial infarction.
作者信息
Friedman H S
机构信息
Department of Medicine, Long Island College Hospital, State University of New York, Health Solence Center at Brooklyn, New York 11201, USA.
出版信息
J R Soc Med. 1996 Aug;89(8):427-30. doi: 10.1177/014107689608900804.
Abstract
摘要
相似文献
1
Streptokinase versus alteplase in acute myocardial infarction.急性心肌梗死中链激酶与阿替普酶的比较
J R Soc Med. 1996 Aug;89(8):427-30. doi: 10.1177/014107689608900804.
2
Controlled trials comparing reteplase with alteplase and streptokinase in patients with acute myocardial infarction.在急性心肌梗死患者中比较瑞替普酶与阿替普酶和链激酶的对照试验。
Pharmacotherapy. 1996 Sep-Oct;16(5 Pt 2):137S-140S.
3
Trials of the European Working Party on streptokinase and of the European Cooperative Study Group on alteplase in patients with acute myocardial infarction. European Investigators.欧洲链激酶工作组及欧洲急性心肌梗死患者阿替普酶合作研究组的试验。欧洲研究者们。
J Interv Cardiol. 1995 Dec;8(6):611-21. doi: 10.1111/j.1540-8183.1995.tb00910.x.
4
5
Thrombolytic therapy in acute myocardial infarction.
Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:241-6. doi: 10.1023/a:1007731612283.
6
[Thrombolytic therapy in acute myocardial infarction--update].[急性心肌梗死的溶栓治疗——最新进展]
Harefuah. 1996 Jun 2;130(11):751-7.
7
8
Current state of thrombolytic therapy.
Curr Cardiol Rep. 1999 Sep;1(3):212-20. doi: 10.1007/s11886-999-0025-9.
9
Another coronary reperfusion regimen.另一种冠状动脉再灌注方案。
Lancet. 1995 Aug 5;346(8971):324-5. doi: 10.1016/s0140-6736(95)92219-9.
10
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.糖尿病对急性心肌梗死溶栓时代临床结局的影响。GUSTO-I研究人员。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1997 Jul;30(1):171-9. doi: 10.1016/s0735-1097(97)00118-6.
引用本文的文献
1
Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.急性心肌梗死的溶栓治疗：比较加速型组织型纤溶酶原激活剂和链激酶的研究分析
J Accid Emerg Med. 1999 Nov;16(6):407-11. doi: 10.1136/emj.16.6.407.
本文引用的文献
1
Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1.
Ann Intern Med. 1993 Sep 15;119(6):530-2. doi: 10.7326/0003-4819-119-6-199309150-00017.
2
Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Ann Intern Med. 1994 May 15;120(10):876-81; discussion 882-5. doi: 10.7326/0003-4819-120-10-199405150-00009.
3
The nonsedating antihistamine scare.非镇静性抗组胺药恐慌。
Clin Cardiol. 1994 Jan;17(1):1.
4
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.加拿大和美国急性心肌梗死后医疗资源的使用及生活质量
N Engl J Med. 1994 Oct 27;331(17):1130-5. doi: 10.1056/NEJM199410273311706.
5
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.大型心肌再灌注随机试验中血管造影亚研究与死亡率结局之间的联系。早期和完全梗死动脉再灌注的重要性。GUSTO-I研究人员。
Circulation. 1995 Apr 1;91(7):1923-8. doi: 10.1161/01.cir.91.7.1923.
6
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators.急性心肌梗死再灌注时代30天死亡率的预测因素。来自一项针对41021例患者的国际试验的结果。GUSTO-I研究人员。
Circulation. 1995 Mar 15;91(6):1659-68. doi: 10.1161/01.cir.91.6.1659.
7
The demise of the randomized controlled trial.随机对照试验的衰落。
J Clin Epidemiol. 1995 Jul;48(7):985-8. doi: 10.1016/0895-4356(94)00203-3.
8
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.美国及其他国家急性心肌梗死患者管理与治疗结果的差异。GUSTO试验结果。全球应用链激酶和组织型纤溶酶原激活剂治疗闭塞冠状动脉研究。
JAMA. 1995;273(20):1586-91. doi: 10.1001/jama.273.20.1586.
9
The effects of the rate of intravenous infusion of streptokinase and the duration of symptoms on the time interval to reperfusion in patients with acute myocardial infarction.链激酶静脉输注速率及症状持续时间对急性心肌梗死患者再灌注时间间隔的影响。
Circulation. 1985 Nov;72(5):1053-8. doi: 10.1161/01.cir.72.5.1053.
10
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.心肌梗死溶栓治疗（TIMI）试验，I期：静脉注射组织型纤溶酶原激活剂与静脉注射链激酶的比较。直至出院的临床结果。
Circulation. 1987 Jul;76(1):142-54. doi: 10.1161/01.cir.76.1.142.
Zotero 插件